Revised CDSCO Cosmetic Sampling Guidelines: What Indian Beauty Manufacturers Should Strengthen Now

India’s cosmetic quality conversation is becoming more structured beyond the factory gate.

On 26 May 2026, the Central Drugs Standard Control Organisation (CDSCO) released revised Regulatory Guidelines for Sampling of Drugs, Cosmetics and Medical Devices by Drugs Inspectors of Central and State Drug Authorities. The revision supersedes the February 2024 version and strengthens the reporting framework around Not of Standard Quality (NSQ) and spurious products. The revised document also continues a structured approach to sample selection, locations, quantities, timelines, monitoring and laboratory testing. Official CDSCO guideline

For a cosmetic brand, this is not simply an inspector-facing document. It is a useful signal about the level of post-market quality readiness manufacturers should build into their operating systems.

What changed in 2026?

The revised framework retains the broad sampling architecture introduced in 2024 but adds more structured reporting for products identified as NSQ or spurious. The new Annexure 6 provides a detailed NSQ alert format, while Annexure 7 provides a structured spurious-product alert format. The guidelines also require monthly reporting and publication of alerts through the CDSCO system. CDSCO

The practical message for manufacturers is straightforward:

If a product is sampled in the market, your ability to trace, explain and support that batch matters.

Post-market surveillance starts with manufacturing records

A common misconception is that quality control ends when a finished batch passes its release checks.

It does not.

Once the product enters distribution, the business needs to be able to connect the market unit back to the manufacturing record.

That means maintaining a reliable chain between:

Raw materials → batch manufacturing record → finished batch → packaging → release → dispatch → market.

If a regulator or brand quality team asks about a particular batch, the response should not depend on memory or scattered spreadsheets.

The batch should have an identifiable documentary trail.

Batch traceability is becoming a commercial capability

For B2B manufacturers, traceability is often discussed as a compliance requirement.

It should also be treated as a customer-service capability.

A brand owner wants to know:

• Which raw-material lots went into the batch?
• Which finished-product batch was supplied?
• When was it manufactured?
• What quality checks were completed?
• Which packaging components were used?
• Where was the batch dispatched?
• What retained sample is available?

A strong traceability system reduces the time required to answer these questions.

That matters even when there is no regulatory issue. It makes investigations, complaints, recalls, product-development changes and customer audits easier to manage.

Retained samples deserve more attention

A retained sample is more than a bottle kept on a shelf.

It is a physical reference for the finished batch.

If a customer reports an unusual change in colour, odour, viscosity, separation or packaging behaviour months after production, the retained sample can help the quality team compare the market unit with the batch as released.

For cosmetic manufacturers, the retained-sample system should therefore be controlled through a defined procedure covering:

• Batch identification
• Product name and variant
• Manufacturing date
• Expiry or best-before information where applicable
• Quantity retained
• Storage conditions
• Location
• Retention period
• Retrieval and disposal records

The exact retention approach should be aligned with the manufacturer’s quality system and applicable requirements.

The 2026 framework makes quality documentation more valuable

The revised NSQ reporting format captures considerably more information than a simple product-and-batch notification. The updated fields include product and brand information, manufacturer details, manufacturing state, dates, batch number, reporting source and the NSQ result. Industry regulatory analysis has highlighted this increased granularity as a key feature of the revision. ChemLinked analysis

For manufacturers, that reinforces a simple principle:

The more precisely your internal records identify the product, the easier it is to respond when an external record identifies it.

Why packaging quality can become a surveillance issue

Post-market quality is not limited to the formula.

A product can be chemically acceptable and still create problems through:

• Damaged or illegible labels
• Poor closure integrity
• Leaking packs
• Incorrect batch coding
• Mismatched product and packaging components
• Tampered or damaged outer packaging

The revised sampling framework also emphasises risk-based selection and scrutiny of suspicious supply chains and products with poor packaging or tampered labels. PTI report

This is why packaging QA should not be treated as a cosmetic finishing step.

It is part of product quality.

What procurement teams should ask a manufacturer

If you are a procurement head or category manager selecting a contract manufacturer, add these questions to your evaluation process:

1. How is batch traceability maintained?

Ask whether raw-material, production and packaging records can be connected to a finished batch.

2. How are retained samples controlled?

Ask where they are stored, how they are identified and how they can be retrieved.

3. How are market complaints investigated?

A mature manufacturer should have a documented process rather than handling complaints informally.

4. How are deviations handled?

Ask how manufacturing deviations, rejected batches and corrective actions are documented.

5. How is change control managed?

Changes to raw materials, packaging, suppliers or formulation parameters can affect product consistency. A controlled change process helps prevent unexpected variation.

6. Can the manufacturer support an audit?

For established brands and export-oriented businesses, audit readiness is an important indicator of operational maturity.

What D2C founders should understand

A D2C founder may initially focus on formulation, branding and launch speed.

That is understandable.

But as the brand grows, quality questions become more operational:

Can the next 10 batches look and perform like the first one?

That is where a contract manufacturer’s systems become strategically important.

A manufacturer with disciplined SOPs, batch records, quality checks and traceability can help a brand scale without turning every customer complaint into an investigation from scratch.

Why risk-based sampling changes the mindset

The revised guidelines direct inspectors toward more systematic sampling across jurisdictions and risk-based considerations. The framework also calls for sampling plans and monitoring data to inform future sampling activity. PTI

Manufacturers should not interpret this as a reason to “prepare for inspection” only.

The better approach is to operate as though every batch must be explainable after it leaves the factory.

That is a much stronger quality culture.

A practical post-market readiness checklist

Before scaling a cosmetic SKU, verify that the manufacturer can demonstrate:

• Clear batch numbering
• Complete batch manufacturing records
• Raw-material lot traceability
• Packaging-component traceability
• Finished-product release checks
• Controlled retained samples
• Complaint handling procedure
• Deviation and CAPA records
• Change-control procedure
• Dispatch records
• Clear responsibility for regulatory responses

These controls create resilience even when no regulator ever samples the product.

Why this matters for contract manufacturing

A contract manufacturer is not only producing physical inventory.

It is creating the quality history behind that inventory.

That history becomes increasingly important as brands move from small launches to repeat commercial production, marketplace distribution and larger procurement programmes.

At Vaishnavi Gramodyog, our B2B manufacturing model is built around controlled production across Haircare, Face Care, Body Care and Glycerine Soap. Our stated operating model includes pilot MOQ from 100 units, batches from 100–1,000 units and typical lead times of 15–20 working days, subject to the project and product.

For a brand, the important question is not only “Can you manufacture this?”

It is:

“Can you manufacture it consistently, trace it properly and support the product after it reaches the market?”

That is the quality question worth asking before the purchase order is raised.

Conclusion

The May 2026 CDSCO revision is fundamentally about stronger and more structured post-market surveillance.

For cosmetic manufacturers and brands, the practical lesson is broader than sampling itself.

Build systems that make every batch explainable.

Maintain traceability.

Control retained samples.

Treat packaging as part of quality.

Document deviations and changes.

And make complaint investigation a defined process rather than an emergency exercise.

The strongest quality system is not the one that looks impressive during an audit. It is the one that still works when a product is already in the market.

FAQs

What are the 2026 CDSCO revised sampling guidelines?

They are revised guidelines governing how Drugs Inspectors of central and state authorities sample drugs, cosmetics and medical devices, including sampling plans, locations, quantities, timelines, monitoring, laboratory testing and NSQ/spurious alerts.

Did the 2026 revision change cosmetic sample quantities?

Industry regulatory analysis reports that the cosmetic sampling quantities in the framework remain unchanged; the major revision is the more structured reporting and alert system. ChemLinked

Why are retained samples important for cosmetic manufacturers?

They provide a physical reference for a finished batch and can support investigation of complaints, changes or quality questions after the product has entered the market.

What is batch traceability?

It is the ability to connect a finished product batch with relevant manufacturing, raw-material, packaging and distribution records.

What should a D2C brand ask its contract manufacturer?

Ask about batch traceability, retained samples, complaint handling, deviations, CAPA, change control, quality release and audit readiness.

Does post-market surveillance affect packaging?

Yes. Packaging integrity, labelling, batch coding and closure performance can all contribute to product-quality and traceability outcomes.

Internal Links

• Custom Formulation & Product Development
• Quality & Certifications
• Contract Manufacturing
• Haircare Manufacturing
• Face Care Manufacturing
• Body Care Manufacturing
• Glycerine Soap Manufacturing
• Contact / Request a Quote

CTA

Before your next commercial production run, ask your manufacturer to demonstrate the complete batch-to-market traceability pathway.